BioCryst Pharmaceuticals

BioCryst Pharmaceuticals, Inc.
Industry Healthcare
Founded 1986
Headquarters Durham, North Carolina, USA
Key people
Jon P. Stonehouse , President and Chief Executive Officer
Thomas Staab II, Chief Financial Officer
Products Biotechnology
Revenue IncreaseUS$26.3M (FY 2012)[1]
DecreaseUS$-33.9M (FY 2012)[1]
DecreaseUS$-39.1M (FY 2012)[1]
Total assets DecreaseUS$57.4M (FY 2012)[2]
Total equity DecreaseUS$-0.4M (FY 2012)[2]
Number of employees
37 (2013)

BioCryst Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Durham, North Carolina.[3] The company focuses on orphan & autoimmune diseases, and antivirals.[3] The company's most advanced drug candidate is the antiviral Peramivir, which is approved in Japan, Korea and China. It was authorized by the FDA for emergency use in the treatment of patients hospitalized with influenza during the 2009-10 influenza A virus subtype H1N1[4] pandemic.


The company was founded in 1986 by Charles E. Bugg, Ph.D. and John A. Montgomery, Ph.D. In March 1994, BioCryst became a public company when it completed an Initial Public Offering by listing its shares on the NASDAQ stock exchange. In 2008 the company was named one of the fastest growing companies by Deloitte & Touche in its 2008 list of Technology Fast 500.[5]

In October 2010, BioCryst announced its headquarters would move to Durham, North Carolina, where the company has had an office since 2006.[6]



  1. 1 2 3 BioCryst Pharmaceuticals (BCRX) annual SEC income statement filing via Wikinvest.
  2. 1 2 BioCryst Pharmaceuticals (BCRX) annual SEC balance sheet filing via Wikinvest.
  3. 1 2 "BioCryst Pharmaceuticals". BioCryst Pharmaceuticals. Retrieved September 26, 2013.
  4. "Emergency use authorization for the unapproved drug Peramivir" (PDF). U.S. Centers for Disease Control and Prevention. Archived from the original (PDF) on November 22, 2009. Retrieved October 28, 2009.
  5. BioCryst named 29th fastest growing tech firm Birmingham Business Journal, November 26, 2008
  6. Ranii, David (October 14, 2010). "BioCryst moving HQ to Durham". News & Observer. Retrieved October 14, 2010.

External links

This article is issued from Wikipedia - version of the 11/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.